Table 2.

Association between miR-195 expression and clinical characteristics of hepatocellular carcinoma

Clinical Characteristics	NO	Change Fold (Mean ± SD)	P value#
Gender
Male	69	-2.66±3.66	0.281
Female	23	-3.64±4.14
Age
≥50	58	-2.22±3.26	0.022*
<50	34	-4.07±4.35
Hepatitis History
Yes	27	-3.12±4.30	0.722
No	65	-2.81±3.58
Tumor Size
≥5 cm	45	-3.70±3.63	0.048*
<5 cm	47	-2.14±3.81
LN metastasis
Yes	15	-3.27±3.95	0.686
No	77	-2.83±3.77
Portal Vein Thrombosis
Yes	20	-4.93±5.47	0.006**
No	72	-2.34±2.98
AFP
High	46	-3.52±3.74	0.119
Low	46	-2.29±3.77
TNM
I, II	41	-1.45±3.12	0.001**
III, IV	51	-4.07±3.89

^#One Way ANOVA was used;

^*P<0.05;

^**P<0.01.